Medical News

RSS

Psychology professor examines factors that motivate men to go on shooting rampage

Maurice Clemmons' fatal shooting of four Washington state police officers once again put the spotlight on mass murder in the United States. Coming on the heels of the November killings at Fort Hood, the Washington case raised questions about the factors that motivate men to go on a shooting rampage.

14 Dec 2009

Union Securities serves as exclusive lead agent for Titan

Titan Medical Inc. is pleased to announce that it has agreed that Union Securities Ltd. will serve as the sole lead agent in connection with the previously announced private placement offering of units by Titan and that the offering will not be syndicated.

14 Dec 2009

Allen & Caron selected as Ohr Pharmaceutical's agency for investor relations

Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.

14 Dec 2009

Detroit-area residents plead guilty in connection with health care fraud schemes

Detroit-area residents Baskaran Thangarasan, Sandeep Aggarwal and Wayne Smith pleaded guilty this week for their roles in connection with several Detroit-area health care fraud schemes, Assistant Attorney General Lanny Breuer of the Criminal Division, U.S. Attorney for the Eastern District of Michigan Terrence I. Berg, Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office and Daniel Levinson, Inspector General for the U.S. Department of Health and Human Services (HHS) announced today.

14 Dec 2009

Psychopharmacology expert calls for more mental health staffing at army bases

The recent shootings at the Ft. Hood, Texas army base, allegedly by an army psychiatrist, have placed much-needed focus on mental health care in the army. In an article published in the December issue of the journal CNS Spectrum, renowned psychopharmacology expert Stephen M. Stahl, MD, PhD, calls for increased mental health staffing at Fort Hood and other army bases.

14 Dec 2009

Dr. Reddy’s Laboratories selects MIDAS from Bodhtree Consulting

Bodhtree Consulting, (www.bodhtree.com) an IT Services Innovator, Data Management and Integration Company announced today that Dr. Reddy’s Laboratories has selected its Data Management and Integration engine MIDAS (Multi Industry Data Anomaly Solution) to address its mission critical application integration challenges.

14 Dec 2009

New eCTD document service speeds up drug approval process

The eCTD format was chosen partly because it makes copying, pasting, viewing, printing and annotating documents much easier. Yet making sure the documents are formatted properly can be a complex job involving a great deal of management and juggling.

14 Dec 2009

Michigan Legislature passes new legislation for smoke-free workplaces

The Michigan State Medical Society (MSMS) today applauded the wisdom of the Michigan legislature to enact legislation to make workplaces in our state smoke-free.

14 Dec 2009

ICON expands its European Central Laboratory in Dublin

ICON plc,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has expanded its European Central Laboratory, located in South County Business Park, Dublin.

14 Dec 2009

MHI launches new research program in heart failure

The Montreal Heart Institute (MHI) and its Foundation (MHIF) launched today the Carolyn and Richard J. Renaud Research Chair in Heart Failure, the first of its kind in Québec.

14 Dec 2009

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

A novel class of cancer therapies called live biologics is offering new hope for patients affected by hard-to-treat cancers, according to two different studies testing the therapies in patients with sarcomas and head and neck cancers.

14 Dec 2009

LABORIE and meridianEMR integrate their EMR and Urodynamic system for Urologists

As the U.S. ramps up the implementation of EMRs in medical practices in order to lower costs, prevent errors, and improve patient care, meridianEMR and LABORIE MEDICAL have provided a great benefit to Urologists using LABORIE urodynamic systems.

14 Dec 2009

BIO commends the House of Representatives for including provisions to ease regulatory burdens

The Biotechnology Industry Organization (BIO) commends the House of Representatives for including provisions intended to ease small business regulatory burdens as part of the Wall Street Reform and Consumer Protection Act of 2009 (H.R. 4173) which passed today.

14 Dec 2009

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study (RIBBON 2) of Avastin® (bevacizumab) in women who had previously been treated with initial (first-line) chemotherapy for advanced HER2-negative breast cancer and needed additional (second-line) treatment.

14 Dec 2009

Hormone therapy: An important treatment option for post-menopausal women

In connection with the New York Times’ recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper’s account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines.

14 Dec 2009

Trial date set for patent litigation in the U.S. District Court for the District of Delaware

Cubist Pharmaceuticals, Inc. today announced that a trial date has been set for patent litigation in the U.S. District Court for the District of Delaware against Teva Parenteral Medicines, Inc. (TPM), Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. alleging infringement of Cubist’s US Patent Nos. 6,468,967 and 6,852,689, which expire on September 24, 2019, and US Patent No. RE39,071, which expires on June 15, 2016.

14 Dec 2009

CTRC-AACR San Antonio Breast Cancer Symposium presents new data on emerging breast cancer therapies

Breast cancer continues to be a dynamic field of research, and the CTRC-AACR San Antonio Breast Cancer Symposium, now in its 32nd year, is the premier destination to present new data on emerging therapies.

14 Dec 2009

Breast Cancer Fund: It's time for the FDA to issue immediate ban on BPA in hard plastic food containers

It's been almost two weeks since the Food and Drug Administration missed its deadline to announce the results of a new safety assessment of the toxic plastics chemical bisphenol A, or BPA, and each day more newborn babies and pregnant women are left unprotected from this hormone-disrupting compound linked to breast cancer and birth defects.

14 Dec 2009

Analysis of mortality and quality of life in ICU patients

An unavoidable question in Intensive Medical Care is how many improve or recover the quality of life they had prior to admission to an Intensive Medical Care Unit (ICU) and how many disimprove and to what degree.

14 Dec 2009

Synexus organises conference to raise awareness of the role of clinical research in drug development

Synexus in Poland organised the first ‘Importance of Clinical Trials in Medical Practice’ conference last week, in conjunction with Wroclaw Medical University. The event, targeting senior medical professionals, aimed to raise awareness of the role of clinical research in drug development and the importance of the business to Poland.

From AES - Accelerated Enrollment Solutions 14 Dec 2009

Medical News

Psychology professor examines factors that motivate men to go on shooting rampage

Union Securities serves as exclusive lead agent for Titan

Allen & Caron selected as Ohr Pharmaceutical's agency for investor relations

Detroit-area residents plead guilty in connection with health care fraud schemes

Psychopharmacology expert calls for more mental health staffing at army bases

Dr. Reddy’s Laboratories selects MIDAS from Bodhtree Consulting

New eCTD document service speeds up drug approval process

Michigan Legislature passes new legislation for smoke-free workplaces

ICON expands its European Central Laboratory in Dublin

MHI launches new research program in heart failure

Oncolytics Biotech develops REOLYSIN for patients affected by hard-to-treat cancers

LABORIE and meridianEMR integrate their EMR and Urodynamic system for Urologists

BIO commends the House of Representatives for including provisions to ease regulatory burdens

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Hormone therapy: An important treatment option for post-menopausal women

Trial date set for patent litigation in the U.S. District Court for the District of Delaware

CTRC-AACR San Antonio Breast Cancer Symposium presents new data on emerging breast cancer therapies

Breast Cancer Fund: It's time for the FDA to issue immediate ban on BPA in hard plastic food containers

Analysis of mortality and quality of life in ICU patients

Synexus organises conference to raise awareness of the role of clinical research in drug development

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News